X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Phase I Trial of The South Korean DuoChol Vaccine In Sweden

    EU Drug Manufacturing Law Changes Disappoint Manufacturers

    AMR Is The Main Focus of New Research Consortium In World

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Gene Silencing Alzheimers Drug, A World First, Shows Promise

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Australia Falling Short In Biotech Research Funding – Study

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Viral Infections Curbed By Gene Scissors In Human Cells

    Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment

    Neurodevelopmental Issue Leads To Testicular Cancer Risk

    Tumors Can Get Destroyed By Bacteria-Aid To Immune System

    Malaria Immunity Boosted By Matrix-M, Saponin Based Adjuvant

    The UK begins the biggest ever immunization program

    New Approach Brought By Singapore For Pneumococcal Vaccines

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Phase I Trial of The South Korean DuoChol Vaccine In Sweden

    EU Drug Manufacturing Law Changes Disappoint Manufacturers

    AMR Is The Main Focus of New Research Consortium In World

    Korean Company GenKOre Offering Genetic Base-Editing Tech

    Gene Silencing Alzheimers Drug, A World First, Shows Promise

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Australia Falling Short In Biotech Research Funding – Study

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Viral Infections Curbed By Gene Scissors In Human Cells

    Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment

    Neurodevelopmental Issue Leads To Testicular Cancer Risk

    Tumors Can Get Destroyed By Bacteria-Aid To Immune System

    Malaria Immunity Boosted By Matrix-M, Saponin Based Adjuvant

    The UK begins the biggest ever immunization program

    New Approach Brought By Singapore For Pneumococcal Vaccines

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Phase I Trial of The South Korean DuoChol Vaccine In Sweden

Content Team by Content Team
3rd May 2023
in Drug Development, News

The South Korea-based International Vaccine Institute- IVI has gone ahead with the clinical manufacturing of DuoChol, a new low-cost oral vaccine for cholera in capsule form. The development has received funding support from the Wellcome Trust as well as the Swedish government, and the IVI is on the verge of conducting the first phase of the trial in Sweden.

DuoChol developed by University of Gothenburg researchers is a dry formulation of inactivated bacterial and a whole cell or cholera toxin B subunit OCV, which have a similar composition as the first in the world, WHO-prequalified OCV named DUKORAL.

Although DUKORAL and the presently available low-cost OCVs Shanchol and Euvichol-Plus, which are pre-qualified by WHO and developed by IVI, happen to be drinkable vaccines, what sets DuoChol on a different spectrum is that it is a dry formulation in capsule form. Because of this, the vaccine’s thermostability, i.e., the stability of the active ingredients, is there, and that too at a relatively higher temperature for longer durations, with both the weight and the volume reduced.

It is well to be noted that IVI is conducting this study in collaboration with one of the biopharmaceutical companies that is spun-off from the University of Gothenburg plus a Swedish subsidiary of specialty vaccine firm zeroed upon as the contract manufacturing organisation. Notably, DuoChol will be manufactured by the Swedish firm as per good manufacturing practises for pre-clinical toxicity testing as well as the Phase 1 trial.

Previous Post

EU Drug Manufacturing Law Changes Disappoint Manufacturers

Related Posts

Drug Development

EU Drug Manufacturing Law Changes Disappoint Manufacturers

3rd May 2023
News

AMR Is The Main Focus of New Research Consortium In World

2nd May 2023
Korean Company GenKOre Offering Genetic Base-Editing Tech
Drug Development

Gene Silencing Alzheimers Drug, A World First, Shows Promise

29th April 2023
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
News

Australia Falling Short In Biotech Research Funding – Study

29th April 2023
Catalent acquires cell and gene therapy-focused MaSTherCell for $315m
News

Viral Infections Curbed By Gene Scissors In Human Cells

29th April 2023
Merck, Junshi Biosciences collaborate to explore head, neck cancer treatment
News

Neurodevelopmental Issue Leads To Testicular Cancer Risk

27th April 2023

Latest News

Drug Development

Phase I Trial of The South Korean DuoChol Vaccine In Sweden

3rd May 2023
Drug Development

EU Drug Manufacturing Law Changes Disappoint Manufacturers

3rd May 2023
News

AMR Is The Main Focus of New Research Consortium In World

2nd May 2023
Korean Company GenKOre Offering Genetic Base-Editing Tech
Drug Development

Gene Silencing Alzheimers Drug, A World First, Shows Promise

29th April 2023
As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits
News

Australia Falling Short In Biotech Research Funding – Study

29th April 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In